An End To Breast Cancer?

 An estimated one in eight women will develop breast cancer in their lifetime, killing on average 42,000 women a year in the United States. 

What if there was a vaccine that would significantly lower each woman's chance of ever getting it in the first place?  

A groundbreaking vaccine created through decades of research at the Cleveland Clinic and developed by Anixa Biosciences in San Jose, California is driving innovation by targeting triple-negative breast cancer, the disease's deadliest and most aggressive form. https://www.cbsnews.com/sacramento/news/an-end-to-breast-cancer-norcal-company-develops-groundbreaking-vaccine-with-promising-future/